Bellerophon Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Bellerophon Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q3 2023.
  • Bellerophon Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2023 was $0.000, a 100% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $0 -$357K -100% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $0 -$529K -100% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $8K -$689K -98.9% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $184K -$679K -78.7% Dec 31, 2022 10-Q 2023-11-14
Q3 2022 $357K -$669K -65.2% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $529K -$659K -55.5% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $697K -$650K -48.3% Mar 31, 2022 10-Q 2022-05-11
Q4 2021 $863K -$641K -42.6% Dec 31, 2021 10-K 2023-03-31
Q3 2021 $1.03M -$633K -38.2% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $1.19M -$623K -34.4% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $1.35M -$614K -31.3% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 $1.5M -$606K -28.7% Dec 31, 2020 10-K 2022-03-31
Q3 2020 $1.66M -$597K -26.5% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $1.81M -$254K -12.3% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $1.96M -$228K -10.4% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $2.11M +$2.11M Dec 31, 2019 10-K 2021-03-11
Q3 2019 $2.26M Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $2.07M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $2.19M Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $0 Dec 31, 2018 10-K 2020-04-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.